BRKRBRUKER CORP同业对比
BRUKER CORP 与iShares Biotechnology ETF 持仓的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:IBB 前十大持仓| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BRKR本股 | $9.7B#12 | — | 4.0x#2 | 2.8x#1 | 2.1%#11 | -107.3%#13 | 2.0%#11 | -0.3%#10 | 0.0%#10 | 5#3 | 109.2%#1 | 0.2%#3 |
| VRTX | $133.4B#4 | 30.7x#5 | 6.6x#4 | 11.1x#8 | 8.9%#8 | 838.1%#3 | 34.8%#2 | 19.5%#6 | 25.0%#5 | — | — | — |
| AMGN | $224.2B#2 | 25.8x#4 | 19.2x#7 | 6.1x#4 | 10.0%#7 | 88.5%#7 | 24.7%#7 | 66.0%#2 | 15.1%#7 | — | — | 2.3%#1 |
| GILD | $187.1B#3 | — | 15.8x#6 | 6.4x#5 | 2.4%#9 | 1672.9%#2 | 34.0%#3 | 71.9%#1 | 26.7%#4 | — | — | 2.1%#2 |
| REGN | — | 19.5x#2 | — | — | 1.0%#12 | 2.1%#9 | 24.9%#6 | 14.2%#7 | 9.4%#9 | — | — | — |
| ARGX | $59.4B#6 | — | — | 1671.1x#12 | 254.4%#1 | 55.1%#8 | 2965.7%#1 | — | — | — | 34.9%#2 | — |
| ALNY | $34.2B#8 | 44.6x#6 | 25.3x#8 | 9.2x#6 | 65.2%#3 | 212.8%#4 | 13.5%#9 | 23.2%#4 | 150.5%#1 | — | — | — |
| NTRA | $59.4B#5 | — | 32.6x#9 | 25.8x#9 | 35.9%#5 | -9.3%#10 | -13.4%#12 | -11.4%#11 | -18.0%#11 | — | — | — |
| BIIB | $33.6B#9 | 24.5x#3 | 2.3x#1 | 3.4x#2 | 2.2%#10 | -20.8%#11 | 28.7%#5 | 8.7%#8 | 13.0%#8 | 4#4 | — | — |
| ILMN | $40.8B#7 | 50.4x#7 | 14.4x#5 | 9.4x#7 | -0.7%#13 | 169.5%#5 | 18.6%#8 | 30.0%#3 | 22.0%#6 | 7#1 | — | — |
| INSM | $25.7B#10 | — | 34.0x#10 | 42.4x#10 | 66.7%#2 | -39.7%#12 | -205.6%#13 | -168.6%#12 | -163.0%#12 | 3#5 | — | — |
| ONC | $533.9B#1 | 840.1x#8 | 103.2x#11 | 99.9x#11 | 40.2%#4 | 144.5%#6 | 8.4%#10 | 5.5%#9 | 29.9%#3 | 6#2 | — | — |
| INCY | $24.8B#11 | 17.5x#1 | 4.4x#3 | 4.8x#3 | 21.2%#6 | 3846.9%#1 | 29.5%#4 | 22.9%#5 | 49.0%#2 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-27。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议